BridgeMD
New treatment option for Chronic Limb-Threatening Ischemia
Official title Pressure Wire Guidance for Infrapopliteal Artery Interventions
ClinicalTrials.gov ID: NCT06879561
What this study is testing
- What it's testing
- " A prospective, single-center randomized controlled comparison trial. A total of 100 patients with symptoms of chronic limb-threatening ischemia (Rutherford category 5) undergoing endovascular treatment for anterior tibial artery or posterior tibial artery lesions will be included if they meet the inclusion criteria and do not meet any exclusion criteria.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Patient with chronic limb threatening ischemia (Rutherford 5)
- Anterior tibial artery or posterior tibial artery lesions ≥ 10 cm Age ≥19 years
You likely can't join if
- Acute limb ischemia
- Contraindication to antiplatelet or anticoagulation agents:
- Thrombocytopenia (platelet \<100,000/uL)
- Previous cerebral hemorrhage, GI bleeding, other reasons for increased bleeding risk within 6 months
- Pregnant women or women with potential childbearing
- Life expectancy \< 1 year
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.